Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CD274 | Q9NZQ7 | 3/20 | 0.56 |
| ▸ | HTR2C | P28335 | 2/20 | 0.49 |
| ▸ | HTR2A | P28223 | 1/20 | 0.49 |
| ▸ | HTR2B | P41595 | 1/20 | 0.49 |
| ▸ | PNMT | P11086 | 2/20 | 0.48 |
| ▸ | HTR7 | P34969 | 3/20 | 0.47 |
| ▸ | CD44 | P16070 | 1/20 | 0.46 |
| ▸ | MAOB | P27338 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL6207314 | 0.98 | CD274 (0.55) | CD274HTR2CHTR2AHTR2BPNMT | |
| SCHEMBL25405965 | 0.84 | CD274 (0.74) | CD274PNMTHTR7CD44MAOB | |
| SCHEMBL6634850 | 0.84 | CD274 (0.67) | CD274PNMTHTR7CD44MAOB | |
| SCHEMBL11568759 | 0.82 | HTR2B (0.51) | CD274HTR2CHTR2AHTR2BHTR7 | |
| SCHEMBL18554708 | 0.82 | CD274 (0.51) | CD274HTR2CHTR2AHTR2BPNMT | |
| SCHEMBL5086121 | 0.80 | PNMT (0.61) | CD274PNMTHTR7CD44MAOB | |
| SCHEMBL29788066 | 0.79 | HTR2A (0.61) | CD274HTR2CHTR2AHTR2BPNMT | |
| SCHEMBL329913 | 0.79 | HTR2A (0.61) | CD274HTR2CHTR2AHTR2BPNMT | |
| Hydrochloric Acid SCHEMBL11487923 | 0.79 | PNMT (0.59) | CD274PNMTHTR7 | |
| Hydrochloric Acid SCHEMBL915156 | 0.78 | HTR2A (0.59) | CD274HTR2CHTR2AHTR2BPNMT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2013007371-A2 | KINETIC RESOLUTION OF CHIRAL AMINES | ETH ZURICH (CH) | 2013-01-17 | — | — | WO | disclosed |